See more : Kontrol Technologies Corp. (KNR.NE) Income Statement Analysis – Financial Results
Complete financial analysis of HeartBeam, Inc. (BEAT) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of HeartBeam, Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- Genco Corporation (GNCC) Income Statement Analysis – Financial Results
- AVE Science&Technology CO.,LTD (688067.SS) Income Statement Analysis – Financial Results
- BioAdaptives, Inc. (BDPT) Income Statement Analysis – Financial Results
- Ocean Wilsons Holdings Limited (OCN.L) Income Statement Analysis – Financial Results
- Grifols, S.A. (GIFLF) Income Statement Analysis – Financial Results
HeartBeam, Inc. (BEAT)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.heartbeam.com
About HeartBeam, Inc.
HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the rapidly growing field of remote patient monitoring. The company was incorporated in 2015 and is headquartered in Santa Clara, California.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 399.47M | 286.78M | 208.33M | 178.51M | 166.58M | 129.50M | 111.49M | 119.02M | 119.92M | 140.62M | 120.45M | 72.99M | 33.92M | 30.94M | 22.23M | 7.92M |
Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 148.99M | 114.41M | 78.88M | 71.96M | 73.11M | 50.43M | 45.59M | 49.08M | 47.49M | 48.69M | 39.91M | 25.53M | 12.70M | 0.00 | 16.97M | 5.66M |
Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 250.49M | 172.37M | 129.45M | 106.56M | 93.46M | 79.07M | 65.90M | 69.95M | 72.43M | 91.93M | 80.54M | 47.47M | 21.22M | 30.94M | 5.26M | 2.26M |
Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 62.70% | 60.11% | 62.14% | 59.69% | 56.11% | 61.06% | 59.11% | 58.77% | 60.40% | 65.38% | 66.86% | 65.03% | 62.56% | 100.00% | 23.66% | 28.51% |
Research & Development | 6.80M | 5.68M | 255.00K | 133.00K | 41.00K | 11.21M | 11.10M | 8.36M | 7.11M | 7.40M | 7.34M | 4.66M | 5.70M | 4.90M | 5.81M | 4.00M | 3.78M | 3.63M | 0.00 | 2.41M | 4.44M |
General & Administrative | 8.52M | 7.35M | 2.03M | 655.00K | 0.00 | 112.43M | 88.60M | 56.60M | 47.93M | 45.80M | 37.06M | 33.42M | 35.01M | 34.66M | 39.15M | 41.92M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 42.85M | 35.32M | 28.64M | 27.94M | 28.81M | 26.28M | 25.60M | 27.82M | 29.34M | 34.66M | 21.11M | 0.00 | 0.00 | 0.00 | 7.70M | 3.53M |
SG&A | 8.52M | 7.35M | 2.03M | 655.00K | 253.00K | 155.28M | 123.92M | 85.23M | 75.87M | 74.61M | 63.34M | 59.03M | 62.83M | 64.00M | 73.81M | 63.03M | 0.00 | 0.00 | 0.00 | 7.70M | 3.53M |
Other Expenses | 0.00 | 3.00K | 22.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 12.08M | 18.58M | 19.98M | -1.06M | 43.44M | 22.08M | 0.00 | 15.25M | 7.02M |
Operating Expenses | 15.31M | 13.03M | 2.29M | 788.00K | 294.00K | 166.48M | 135.02M | 93.59M | 82.98M | 82.00M | 70.67M | 63.69M | 80.61M | 87.47M | 99.60M | 65.97M | 47.22M | 25.71M | 0.00 | 25.36M | 14.99M |
Cost & Expenses | 15.31M | 13.03M | 2.29M | 788.00K | 294.00K | 315.47M | 249.43M | 172.47M | 154.94M | 155.12M | 121.11M | 109.28M | 129.69M | 134.96M | 148.29M | 105.88M | 72.75M | 38.41M | 0.00 | 42.33M | 20.65M |
Interest Income | 675.00K | 66.00K | 2.17K | 280.00 | 242.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 0.00 | 66.00K | 2.17M | 280.00K | 242.00K | 9.43M | 4.90M | 0.00 | 0.00 | 0.00 | 0.00 | 299.00K | 0.00 | 3.00K | 12.00K | 170.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 15.31M | 13.03M | 2.29M | 788.00K | 294.00K | 40.17M | 28.56M | 14.27M | 12.49M | 12.55M | 12.32M | 9.38M | 12.13M | 12.07M | 10.94M | 8.69M | 4.55M | 2.66M | -42.40M | -848.00K | 46.00K |
EBITDA | 675.00K | -13.03M | 0.00 | -788.00K | -294.00K | 92.05M | 24.25M | 30.04M | 20.38M | 444.00K | 5.21M | -3.43M | -49.05M | -7.52M | -9.52M | 19.55M | 4.19M | -4.99M | -11.46M | -20.95M | -12.68M |
EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 23.04% | 8.46% | 14.42% | 11.42% | 0.27% | 4.03% | -3.08% | -41.21% | -6.27% | -6.77% | 16.23% | 5.74% | -14.71% | -37.05% | -94.22% | -160.04% |
Operating Income | -15.31M | -13.03M | -2.29M | -788.00K | -294.00K | 84.00M | 37.35M | 35.86M | 23.58M | 11.46M | 8.40M | 2.21M | -10.66M | -15.04M | -7.67M | 14.57M | 241.61K | -4.49M | 30.94M | -20.10M | -12.73M |
Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 21.03% | 13.02% | 17.21% | 13.21% | 6.88% | 6.48% | 1.98% | -8.96% | -12.54% | -5.45% | 12.10% | 0.33% | -13.23% | 100.00% | -90.41% | -160.62% |
Total Other Income/Expenses | 675.00K | 69.00K | -2.14M | -280.00K | -242.00K | -42.50M | -47.75M | -20.09M | -15.68M | -23.57M | -15.50M | -15.32M | -50.51M | -4.56M | -12.80M | -3.88M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income Before Tax | -14.64M | -12.96M | -4.43M | -1.07M | -536.00K | 41.50M | -10.40M | 15.77M | 7.90M | -12.11M | -7.10M | -13.11M | -61.18M | -19.60M | -20.47M | 10.69M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 10.39% | -3.63% | 7.57% | 4.42% | -7.27% | -5.49% | -11.76% | -51.40% | -16.34% | -14.56% | 8.87% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Income Tax Expense | 0.00 | -135.00K | 2.17M | 280.00K | 242.00K | -370.00K | 6.75M | -37.67M | 468.00K | -2.31M | 215.00K | -905.00K | 244.00K | 262.00K | 5.00K | 1.48M | 0.00 | 0.00 | 42.40M | 848.00K | -46.00K |
Net Income | -14.64M | -12.83M | -6.59M | -1.35M | -778.00K | 42.82M | -15.96M | 53.44M | 7.43M | -9.79M | -7.32M | -12.20M | -61.42M | -19.86M | -20.48M | 9.21M | -358.07K | -7.64M | -11.46M | -20.95M | -12.68M |
Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 10.72% | -5.56% | 25.65% | 4.16% | -5.88% | -5.65% | -10.94% | -51.61% | -16.56% | -14.56% | 7.64% | -0.49% | -22.54% | -37.05% | -94.22% | -160.04% |
EPS | -0.72 | -1.57 | -0.84 | -0.17 | -0.10 | 1.20 | -0.53 | 1.91 | 0.27 | -0.37 | -0.29 | -0.49 | -2.51 | -0.82 | -0.86 | 0.50 | -0.12 | -2.63 | -4.04 | -7.33 | -5.23 |
EPS Diluted | -0.72 | -1.57 | -0.84 | -0.17 | -0.10 | 1.20 | -0.53 | 1.75 | 0.26 | -0.37 | -0.29 | -0.49 | -2.51 | -0.82 | -0.86 | 0.41 | -0.12 | -2.63 | -4.04 | -7.33 | -5.23 |
Weighted Avg Shares Out | 20.33M | 8.17M | 7.81M | 8.17M | 8.17M | 35.78M | 30.39M | 27.92M | 27.12M | 26.45M | 25.54M | 24.93M | 24.43M | 24.11M | 23.77M | 18.35M | 2.91M | 2.91M | 2.84M | 2.86M | 2.42M |
Weighted Avg Shares Out (Dil) | 20.33M | 8.17M | 7.81M | 8.17M | 8.17M | 35.78M | 30.39M | 30.49M | 29.09M | 26.45M | 25.54M | 24.93M | 24.43M | 24.11M | 23.77M | 22.66M | 2.91M | 2.91M | 2.84M | 2.86M | 2.42M |
10,802 Shares in BioTelemetry Inc (NASDAQ:BEAT) Purchased by Advisor Group Holdings Inc.
Royal Bank of Canada Grows Stake in BioTelemetry Inc (NASDAQ:BEAT)
State of Tennessee Treasury Department Grows Stock Position in BioTelemetry Inc (NASDAQ:BEAT)
Squarepoint Ops LLC Purchases Shares of 9,600 BioTelemetry Inc (NASDAQ:BEAT)
The Global Cardiac Safety Services Market is expected to grow from USD 453.08 Million in 2019 to USD 830.62 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 10.62%
BioTelemetry Inc (NASDAQ:BEAT) Shares Acquired by Alliancebernstein L.P.
BioTelemetry Inc (NASDAQ:BEAT) Expected to Post Quarterly Sales of $85.93 Million
Assessment of COVID-19's Effect on Holter Monitor Market 2020-2024 | Increasing Prevalence of Cardiac Disorders to Augment Growth | Technavio
Global Telemedicine Services Market To Reach Value Of $78 Billion In 2023
Source: https://incomestatements.info
Category: Stock Reports